Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.98 CNY
340.07 M CNY
2.58 B CNY
324.97 M
About GAN & LEE PHARMACEUTICALS.
Sector
CEO
Kai Du
Headquarters
Beijing
Website
Founded
1998
ISIN
CNE100003ZH1
FIGI
BBG00JRS4QC2
Gan & Lee Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of recombinant insulin analogue raw materials and injections. Its products include recombinant insulin glargine injections, recombinant insulin lispro injections, protamine zinc recombinant insulin lispro mixed injections, injection pens and needles. The company was founded by Zhong Ru Gan, Yi Ru Gan and Xi Ru Gan on June 17, 1998 and is headquartered in Beijing, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 603087 is 45.77 CNY — it has increased by 0.53% in the past 24 hours. Watch GAN & LEE PHARMACEUTICALS. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange GAN & LEE PHARMACEUTICALS. stocks are traded under the ticker 603087.
603087 stock has fallen by −1.04% compared to the previous week, the month change is a −0.93% fall, over the last year GAN & LEE PHARMACEUTICALS. has showed a −11.13% decrease.
We've gathered analysts' opinions on GAN & LEE PHARMACEUTICALS. future price: according to them, 603087 price has a max estimate of 68.00 CNY and a min estimate of 60.03 CNY. Watch 603087 chart and read a more detailed GAN & LEE PHARMACEUTICALS. stock forecast: see what analysts think of GAN & LEE PHARMACEUTICALS. and suggest that you do with its stocks.
603087 reached its all-time high on Jul 15, 2020 with the price of 204.41 CNY, and its all-time low was 30.53 CNY and was reached on Oct 12, 2022. View more price dynamics on 603087 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
603087 stock is 1.37% volatile and has beta coefficient of 1.54. Track GAN & LEE PHARMACEUTICALS. stock price on the chart and check out the list of the most volatile stocks — is GAN & LEE PHARMACEUTICALS. there?
Today GAN & LEE PHARMACEUTICALS. has the market capitalization of 27.05 B, it has decreased by −1.51% over the last week.
Yes, you can track GAN & LEE PHARMACEUTICALS. financials in yearly and quarterly reports right on TradingView.
GAN & LEE PHARMACEUTICALS. is going to release the next earnings report on Apr 24, 2025. Keep track of upcoming events with our Earnings Calendar.
603087 earnings for the last quarter are 0.35 CNY per share, whereas the estimation was 0.24 CNY resulting in a 45.83% surprise. The estimated earnings for the next quarter are 0.34 CNY per share. See more details about GAN & LEE PHARMACEUTICALS. earnings.
GAN & LEE PHARMACEUTICALS. revenue for the last quarter amounts to 930.00 M CNY, despite the estimated figure of 1.03 B CNY. In the next quarter, revenue is expected to reach 1.18 B CNY.
603087 net income for the last quarter is 208.36 M CNY, while the quarter before that showed 202.90 M CNY of net income which accounts for 2.69% change. Track more GAN & LEE PHARMACEUTICALS. financial stats to get the full picture.
As of Dec 21, 2024, the company has 4.48 K employees. See our rating of the largest employees — is GAN & LEE PHARMACEUTICALS. on this list?
Like other stocks, 603087 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GAN & LEE PHARMACEUTICALS. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GAN & LEE PHARMACEUTICALS. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GAN & LEE PHARMACEUTICALS. stock shows the sell signal. See more of GAN & LEE PHARMACEUTICALS. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.